Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | May 31, 2023 | Direct | ||
NextCure, Inc. | Director | Stock Option (Right to Buy) | 14.3K | Jun 24, 2021 | Direct | ||
Tempest Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 6.64K | Jul 1, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
DSGN | Design Therapeutics, Inc. | Mar 18, 2022 | 4 | -$11.3M | 4 | Mar 22, 2022 | Director |
TPST | Tempest Therapeutics, Inc. | Jul 1, 2021 | 1 | $0 | 4/A | Sep 20, 2021 | Director |
TPST | Millendo Therapeutics, Inc. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |
TPST | Millendo Therapeutics, Inc. | Jun 25, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director |
NXTC | NextCure, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |